Acetylation of α-tubulin by a histone deacetylase inhibitor, resminostat, leads synergistic antitumor effect with docetaxel in non-small cell lung cancer models
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.